TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC) Investor Securities Class Action Lawsuit 05/01/2017

  • You must submit the settlement Proof form attached below, in order to participate in this settlement. There is a strict deadline of July 24, 2019 by which all claims must be submitted. The instructions for submitting are included in the Proof and the Notice files attached below for your download. DO NOT SEND THE FORMS TO THE SHAREHOL

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Lawsuit Overview

February 4, 2019 - The court preliminarily approved the settlement. September 13, 2018 - A stipulation of settlement was filed by the parties. May 29, 2018 - The court granted the defendants' motion to dismiss. The plaintiffs were given leave to amend the complaint. November 10, 2017 - A motion to dismiss the second amended complaint was filed. October 13, 2017 - A second amended ...



You must register (for free) or login to view the entire case.

Click here to Sign In or Register (for a free account)

@screen width:
@theme:
@breakpoints:
@layout: